Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Appleton, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Augusta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Barberton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Bellingham, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Belpre, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Berlin, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Bismarck, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Boone, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Boulder, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Branson, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Burlington, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Centralia, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Charleston, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Clive, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Danville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Eureka, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Eureka, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Evanston, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Fairfield, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Federal Way, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Fort Scott, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Franklin, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Grand Island, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Greenville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Hartford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Harvey, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Helena, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Huntington, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Hutchinson, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Independence, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Iowa City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Jacksonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Joplin, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Kailua, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Kearney, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Kokomo, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Lihue, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Logan, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Loveland, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Macomb, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Marietta, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Marshalltown, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Middletown, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Minocqua, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Minot, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Monmouth, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Muncie, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 3/17/2016
mi
from
Newark, DE
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 66